Narrow search
Showing 1 - 10 of 1,064
Cover Image
Advertising and competition in the ethical pharmaceutical industry : the case of antihypertensive drugs
Rizzo, John A. - In: The journal of law & economics 42 (1999) 1,1, pp. 89-116
Persistent link: https://www.econbiz.de/10001373467
Cover Image
Demand systems and the true subindex of the cost of living for pharmaceuticals
Baye, Michael R. - In: Applied economics 29 (1997) 9, pp. 1179-1189
Persistent link: https://www.econbiz.de/10001227186
Cover Image
On the demand for prescription drugs : heterogeneity in price responses
Skipper, Niels - In: Health economics 22 (2013) 7, pp. 857-869
Persistent link: https://www.econbiz.de/10009780267
Cover Image
Why do HMOs spend less? : patient selection, physician price sensitivity, and prices
Sacks, Daniel W. - In: Journal of public economics 168 (2018), pp. 146-161
Persistent link: https://www.econbiz.de/10012036011
Cover Image
Demand estimation and merger simulations for drugs : logits v. AIDS
Bokhari, Farasat A. S.; Mariuzzo, Franco - In: International journal of industrial organization 61 (2018), pp. 653-685
Persistent link: https://www.econbiz.de/10012103474
Cover Image
Tiered co-payments, pricing, and demand in reference price markets for pharmaceuticals
Herr, Annika; Suppliet, Moritz - In: Journal of health economics 56 (2017), pp. 19-29
Persistent link: https://www.econbiz.de/10011798902
Cover Image
Price elasticities of pharmaceuticals in a value-based-formulary setting
Yeung, Kai; Basu, Anirban; Hansen, Ryan N.; Sullivan, … - 2016
Persistent link: https://www.econbiz.de/10011495052
Cover Image
Pharmaceutical demand response to utilization management
Sarig, Oren - In: Journal of health economics 93 (2024), pp. 1-18
Persistent link: https://www.econbiz.de/10014451293
Cover Image
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting
Yeung, Kai - 2016
pharmaceuticals, are deemed to be price inelastic with price elasticities of demand (PED) close to -0.20. However, most studies of PED … designed based on drug-specific incremental cost-effectiveness ratios, we estimate price elasticities of pharmaceuticals within … produce positive welfare effects. We estimate an overall PED for pharmaceuticals to be -0.16, close to the estimate of RAND …
Persistent link: https://www.econbiz.de/10012989727
Cover Image
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting
Yeung, Kai - 2016
pharmaceuticals, are deemed to be price inelastic with price elasticities of demand (PED) close to -0.20. However, most studies of PED … designed based on drug-specific incremental cost-effectiveness ratios, we estimate price elasticities of pharmaceuticals within … produce positive welfare effects. We estimate an overall PED for pharmaceuticals to be -0.16, close to the estimate of RAND …
Persistent link: https://www.econbiz.de/10012456367